San Francisco, CA

SF Research Institute

Anxiety Disorders

Body Weight

Psoriasis

Hot Flashes

Child Nutrition Disorders

Eczema

Malnutrition

Growth Disorders

Dermatitis

Atopic Dermatitis

Dupilumab

Deucravacitinib

SF Research Institute, Inc.

Bristol-Myers Squibb (BMS)

Regeneron Pharmaceuticals

TruHeight Vitamins

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

SF Research Institute | San Francisco, CA

Site insights

Work at this site?

Active trials

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting (ARTISTYK)

Trial sponsors